Diverse ubiquitin signaling in NF-κB activation

Trends in Cell Biology

Volumn 22, Issue 7, 2012, Pages 355-364

  Iwai, Kazuhiro ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Linear ubiquitination; LUBAC; NF B; Ubiquitin

Indexed keywords

DNA; I KAPPA B KINASE GAMMA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN; INTERLEUKIN 1BETA; LINEAR UBIQUITIN CHAIN ASSEMBLY COMPLEX; POLYUBIQUITIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PROTEIN WITH A DEATH DOMAIN; UBIQUITIN; UNCLASSIFIED DRUG;

AUTOPHOSPHORYLATION; BINDING AFFINITY; GENE EXPRESSION; HUMAN; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; UBIQUITINATION;

ANIMALS; HUMANS; NF-KAPPA B; PROTEIN BINDING; SIGNAL TRANSDUCTION; UBIQUITIN; UBIQUITINATION;

EID: 84862761186     PISSN: 09628924     EISSN: 18793088     Source Type: Journal    
DOI: 10.1016/j.tcb.2012.04.001     Document Type: Review

References (87)

1. Ciechanover A. Intracellular protein degradation: from a vague idea thru the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting. Cell Death Differ. 2005, 12:1178-1190.
2. Deshaies R.J., Joazeiro C.A. RING domain E3 ubiquitin ligases. Annu. Rev. Biochem. 2009, 78:399-434.
3. Ravid T., Hochstrasser M. Diversity of degradation signals in the ubiquitin-proteasome system. Nat. Rev. Mol. Cell Biol. 2008, 9:679-690.
4. Chen Z.J., Sun L.J. Nonproteolytic functions of ubiquitin in cell signaling. Mol. Cell 2009, 33:275-286.
5. Ikeda F., Dikic I. Atypical ubiquitin chains: new molecular signals. 'Protein Modifications: Beyond the Usual Suspects' review series. EMBO Rep. 2008, 9:536-542.
6. Behrends C., Harper J.W. Constructing and decoding unconventional ubiquitin chains. Nat. Struct. Mol. Biol. 2011, 18:520-528.
7. Skaug B., et al. The role of ubiquitin in NF-κB regulatory pathways. Annu. Rev. Biochem. 2009, 78:769-796.
8. Wertz I.E., Dixit V.M. Signaling to NF-κB: regulation by ubiquitination. Cold Spring Harb. Perspect. Biol. 2010, 2:a003350.
9. Baltimore D. Discovering NF-κB. Cold Spring Harb. Perspect. Biol. 2009, 1:a000026.
10. Hayden M.S., Ghosh S. Shared principles in NF-κB signaling. Cell 2008, 132:344-362.
11. Staudt L.M. Oncogenic activation of NF-kappaB. Cold Spring Harb. Perspect. Biol. 2010, 2:a000109.
12. Ben-Neriah Y., Karin M. Inflammation meets cancer, with NF-κB as the matchmaker. Nat. Immunol. 2011, 12:715-723.
13. Bonizzi G., Karin M. The two NF-κB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 2004, 25:280-288.
14. Chiu Y.H., et al. Ubiquitin in NF-κB signaling. Chem. Rev. 2009, 109:1549-1560.
15. Israel A. The IKK complex, a central regulator of NF-κB activation. Cold Spring Harb. Perspect. Biol. 2010, 2:a000158.
16. Sun S.C. Non-canonical NF-κB signaling pathway. Cell Res. 2011, 21:71-85.
17. Iwai K. Linear polyubiquitin chains: a new modifier involved in NFκB activation and chronic inflammation, including dermatitis. Cell Cycle 2011, 10:3095-3104.
18. Iwai K., Tokunaga F. Linear polyubiquitination: a new regulator of NF-κB activation. EMBO Rep. 2009, 10:706-713.
19. Xia Z.P., et al. Direct activation of protein kinases by unanchored polyubiquitin chains. Nature 2009, 461:114-119.
20. Deng L., et al. Activation of the IκB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 2000, 103:351-361.
21. Newton K., et al. Ubiquitin chain editing revealed by polyubiquitin linkage-specific antibodies. Cell 2008, 134:668-678.
22. Conze D.B., et al. Lys63-linked polyubiquitination of IRAK-1 is required for interleukin-1 receptor- and toll-like receptor-mediated NF-κB activation. Mol. Cell. Biol. 2008, 28:3538-3547.
23. Adhikari A., et al. Ubiquitin-mediated activation of TAK1 and IKK. Oncogene 2007, 26:3214-3226.
24. Yamamoto M., et al. Key function for the Ubc13 E2 ubiquitin-conjugating enzyme in immune receptor signaling. Nat. Immunol. 2006, 7:962-970.
25. Yamazaki K., et al. Two mechanistically and temporally distinct NF-κB activation pathways in IL-1 signaling. Sci. Signal. 2009, 2:ra66.
26. Xu M., et al. A Ubiquitin replacement strategy in human cells reveals distinct mechanisms of IKK activation by TNFα and IL-1β. Mol. Cell 2009, 36:302-314.
27. Kirisako T., et al. A ubiquitin ligase complex assembles linear polyubiquitin chains. EMBO J. 2006, 25:4877-4887.
28. Wickliffe K.E., et al. K11-linked ubiquitin chains as novel regulators of cell division. Trends Cell Biol. 2011, 21:656-663.
29. Tokunaga F., et al. Involvement of linear polyubiquitylation of NEMO in NF-κB activation. Nat. Cell Biol. 2009, 11:123-132.
30. Seymour R.E., et al. Spontaneous mutations in the mouse Sharpin gene result in multiorgan inflammation, immune system dysregulation and dermatitis. Genes Immun. 2007, 8:416-421.
31. Tokunaga F., et al. SHARPIN is a component of the NF-κB-activating linear ubiquitin chain assembly complex. Nature 2011, 471:633-636.
32. Gerlach B., et al. Linear ubiquitination prevents inflammation and regulates immune signalling. Nature 2011, 471:591-596.
33. Zak D.E., et al. Systems analysis identifies an essential role for SHANK-associated RH domain-interacting protein (SHARPIN) in macrophage Toll-like receptor 2 (TLR2) responses. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:11536-11541.
34. Ikeda F., et al. SHARPIN forms a linear ubiquitin ligase complex regulating NF-κB activity and apoptosis. Nature 2011, 471:637-641.
35. Jin L., et al. Mechanism of ubiquitin-chain formation by the human anaphase-promoting complex. Cell 2008, 133:653-665.
36. Dynek J.N., et al. c-IAP1 and UbcH5 promote K11-linked polyubiquitination of RIP1 in TNF signalling. EMBO J. 2010, 29:4198-4209.
37. Bosanac I., et al. Modulation of K11-linkage formation by variable loop residues within UbcH5A. J. Mol. Biol. 2011, 408:420-431.
38. Hunter T., et al. Receptor protein tyrosine kinases and phosphatases. Cold Spring Harb. Symp. Quant. Biol. 1992, 57:25-41.
39. Sato S., et al. Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat. Immunol. 2005, 6:1087-1095.
40. Shim J.H., et al. TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. Genes Dev. 2005, 19:2668-2681.
41. + Neutrophils. Immunity 2012, 36:43-54.
42. Xu G., et al. Crystal structure of inhibitor of κB kinase β. Nature 2011, 472:325-330.
43. Wu C.J., et al. Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-κB activation. Nat. Cell Biol. 2006, 8:398-406.
44. Winget J.M., Mayor T. The diversity of ubiquitin recognition: hot spots and varied specificity. Mol. Cell 2010, 38:627-635.
45. Wagner S., et al. Ubiquitin binding mediates the NF-κB inhibitory potential of ABIN proteins. Oncogene 2008, 27:3739-3745.
46. Laplantine E., et al. NEMO specifically recognizes K63-linked poly-ubiquitin chains through a new bipartite ubiquitin-binding domain. EMBO J. 2009, 28:2885-2895.
47. Rahighi S., et al. Specific recognition of linear ubiquitin chains by NEMO is important for NF-κB activation. Cell 2009, 136:1098-1109.
48. Smahi A., et al. The NF-κB signalling pathway in human diseases: from incontinentia pigmenti to ectodermal dysplasias and immune-deficiency syndromes. Hum. Mol. Genet. 2002, 11:2371-2375.
49. Hubeau M., et al. A new mechanism of X-linked anhidrotic ectodermal dysplasia with immunodeficiency: impairment of ubiquitin binding despite normal folding of NEMO protein. Blood 2011, 118:926-935.
50. Lo Y.C., et al. Structural basis for recognition of diubiquitins by NEMO. Mol. Cell 2009, 33:602-615.
51. Abbott D.W., et al. Coordinated regulation of Toll-like receptor and NOD2 signaling by K63-linked polyubiquitin chains. Mol. Cell. Biol. 2007, 27:6012-6025.
52. Zhou H., et al. Bcl10 activates the NF-κB pathway through ubiquitination of NEMO. Nature 2004, 427:167-171.
53. Gautheron J., Courtois G. "Without Ub I am nothing": NEMO as a multifunctional player in ubiquitin-mediated control of NF-κB activation. Cell. Mol. Life Sci. 2010, 67:3101-3113.
54. Varfolomeev E., et al. IAP antagonists induce autoubiquitination of c-IAPs, NF-κB activation, and TNFα-dependent apoptosis. Cell 2007, 131:669-681.
55. Vince J.E., et al. IAP antagonists target cIAP1 to induce TNFα-dependent apoptosis. Cell 2007, 131:682-693.
56. Haas T.L., et al. Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction. Mol. Cell 2009, 36:831-844.
57. Sato Y., et al. Specific recognition of linear ubiquitin chains by the Npl4 zinc finger (NZF) domain of the HOIL-1L subunit of the linear ubiquitin chain assembly complex. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:20520-20525.
58. Harhaj E.W., Dixit V.M. Deubiquitinases in the regulation of NF-κB signaling. Cell Res. 2011, 21:22-39.
59. Sun S.C. CYLD: a tumor suppressor deubiquitinase regulating NF-κB activation and diverse biological processes. Cell Death Differ. 2010, 17:25-34.
60. Hymowitz S.G., Wertz I.E. A20: from ubiquitin editing to tumour suppression. Nat. Rev. Cancer 2010, 10:332-341.
61. Malynn B.A., Ma A. A20 takes on tumors: tumor suppression by an ubiquitin-editing enzyme. J. Exp. Med. 2009, 206:977-980.
62. Wertz I.E., et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling. Nature 2004, 430:694-699.
63. Shembade N., et al. Inhibition of NF-κB signaling by A20 through disruption of ubiquitin enzyme complexes. Science 2010, 327:1135-1139.
64. Jacque E., Ley S.C. RNF11, a new piece in the A20 puzzle. EMBO J. 2009, 28:455-456.
65. Shembade N., et al. The kinase IKKα inhibits activation of the transcription factor NF-κB by phosphorylating the regulatory molecule TAX1BP1. Nat. Immunol. 2011, 12:834-843.
66. Skaug B., et al. Direct, noncatalytic mechanism of IKK inhibition by A20. Mol. Cell 2011, 44:559-571.
67. Brummelkamp T.R., et al. Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB. Nature 2003, 424:797-801.
68. Kovalenko A., et al. The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination. Nature 2003, 424:801-805.
69. Trompouki E., et al. CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members. Nature 2003, 424:793-796.
70. Komander D., et al. Molecular discrimination of structurally equivalent Lys 63-linked and linear polyubiquitin chains. EMBO Rep. 2009, 10:466-473.
71. Enesa K., et al. NF-kappaB suppression by the deubiquitinating enzyme Cezanne: a novel negative feedback loop in pro-inflammatory signaling. J. Biol. Chem. 2008, 283:7036-7045.
72. Xu G., et al. Ubiquitin-specific peptidase 21 inhibits tumor necrosis factor alpha-induced nuclear factor kB activation via binding to and deubiquitinating receptor-interacting protein 1. J. Biol. Chem. 2010, 285:969-978.
73. Yamamoto M., et al. Cutting edge: pivotal function of Ubc13 in thymocyte TCR signaling. J. Immunol. 2006, 177:7520-7524.
74. Dikic I., et al. Ubiquitin-binding domains - from structures to functions. Nat. Rev. Mol. Cell Biol. 2009, 10:659-671.
75. Zhao S., Ulrich H.D. Distinct consequences of posttranslational modification by linear versus K63-linked polyubiquitin chains. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:7704-7709.
76. Finley D. Recognition and processing of ubiquitin-protein conjugates by the proteasome. Annu. Rev. Biochem. 2009, 78:477-513.
77. Hershko A., Ciechanover A. The ubiquitin system. Annu. Rev. Biochem. 1998, 67:425-479.
78. Rotin D., Kumar S. Physiological functions of the HECT family of ubiquitin ligases. Nat. Rev. Mol. Cell Biol. 2009, 10:398-409.
79. Wenzel D.M., et al. UBCH7 reactivity profile reveals parkin and HHARI to be RING/HECT hybrids. Nature 2011, 474:105-108.
80. Pierce N.W., et al. Detection of sequential polyubiquitylation on a millisecond timescale. Nature 2009, 462:615-619.
81. Spence J., et al. A ubiquitin mutant with specific defects in DNA repair and multiubiquitination. Mol. Cell. Biol. 1995, 15:1265-1273.
82. Peng J., et al. A proteomics approach to understanding protein ubiquitination. Nat. Biotechnol. 2003, 21:921-926.
83. Reyes-Turcu F.E., et al. Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes. Annu. Rev. Biochem. 2009, 78:363-397.
84. Komander D., et al. Breaking the chains: structure and function of the deubiquitinases. Nat. Rev. Mol. Cell Biol. 2009, 10:550-563.
85. Ye Y., Rape M. Building ubiquitin chains: E2 enzymes at work. Nat. Rev. Mol. Cell Biol. 2009, 10:755-764.
86. Hofmann R.M., Pickart C.M. Noncanonical MMS2-encoded ubiquitin-conjugating enzyme functions in assembly of novel polyubiquitin chains for DNA repair. Cell 1999, 96:645-653.
87. Zeng W., et al. Key role of Ubc5 and lysine-63 polyubiquitination in viral activation of IRF3. Mol. Cell 2009, 36:315-325.